google-site-verification: googlec7193c3de77668c9.html
Wednesday , October 28 2026

GLP-1RAs shown to reduce risk of cardiovascular death

[
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown promise in clinical trials for patients with chronic cardiovascular, kidney, and metabolic diseases. Those studies focused mainly on patients with singular diagnoses, but these conditions often overlap.


Source link

Advertisements

See also  Premier League: Arsenal 1-0 Crystal Palace - Oliver Glasner post-match interview

Check Also

How socioeconomic factors affect outcomes in this deadly cancer

[ Black women diagnosed with hormone receptor–positive (HR+) breast cancer experience significantly worse outcomes than …

How socioeconomic factors affect outcomes in this deadly cancer

[ Cellular images show metastatic and nonmetastatic HR+ breast cancer in Black women (upper left …

Wearable EEG patch records stable brain signals over 24 hours, including sleep

[ In its latest study, Fraunhofer IDMT investigated how reliably the flexible “trEEGrid” electrode patch …

Leave a Reply

Available for Amazon Prime